• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比利时的宫颈癌筛查。

Cervical cancer screening in Belgium.

作者信息

Arbyn M, Van Oyen H

机构信息

Scientific Institute of Public Health, J. Wytsmanstreet 14, B-1050, Belgium.

出版信息

Eur J Cancer. 2000 Nov;36(17):2191-7. doi: 10.1016/s0959-8049(00)00308-7.

DOI:10.1016/s0959-8049(00)00308-7
PMID:11072203
Abstract

A description is given of the burden of cervical cancer and the status of screening in Belgium until 1998. Screening is essentially opportunistic and generally performed at yearly intervals. A programme for organised screening - promoting one cervical smear every 3 years for women aged between 25 and 64 years - is being set up in the Flemish Region alone. Important progress has been made concerning the development of technical guidelines on the collection of an adequate Papanicolaou (Pap) smear, uniform terminology for the cytological report and the follow-up of positive tests. The implementation of the programme is confined to the provinces that are instructed to make women and physicians aware of the screening policy. The establishment of a screening register, allowing for individualised invitation of women, was hampered by strict privacy laws and by the heterogeneity of software used for data entry in cytological laboratories. The impact of the Flemish programme was further limited since the reimbursement of smear taking by a gynaecologist or a general practitioner (GP) and the cytological reading are not conditioned by the respect of guidelines. This is due to the fact that the organisation of preventive healthcare and the financing of medical activities concerns distinct authorities. The coverage of the target population is good in Flanders (82.3% according to certain estimates), but is achieved at the expense of an important amount of over-screening. The coverage is lower in the Walloon and the Capital Region. Rationalisation of the policy regarding cancer screening involving all concerned authorities of the country is necessary.

摘要

本文描述了截至1998年比利时宫颈癌的负担情况以及筛查现状。筛查基本上是机会性的,通常每年进行一次。仅在弗拉芒地区正在设立一项有组织的筛查计划,即鼓励25至64岁的女性每三年进行一次宫颈涂片检查。在制定关于采集足够巴氏涂片的技术指南、细胞学报告的统一术语以及阳性检测结果的后续跟进方面已经取得了重要进展。该计划的实施仅限于那些被要求让女性和医生了解筛查政策的省份。由于严格的隐私法以及细胞学实验室用于数据录入的软件的异质性,建立一个能够实现对女性进行个性化邀请的筛查登记册受到了阻碍。弗拉芒地区的计划影响进一步受限,因为妇科医生或全科医生进行涂片采集以及细胞学解读的费用报销并不以遵循指南为条件。这是因为预防性医疗保健的组织和医疗活动的资金由不同的当局负责。弗拉芒地区目标人群的覆盖率良好(根据某些估计为82.3%),但这是以大量过度筛查为代价实现的。瓦隆地区和首都地区的覆盖率较低。有必要使涉及该国所有相关当局的癌症筛查政策合理化。

相似文献

1
Cervical cancer screening in Belgium.比利时的宫颈癌筛查。
Eur J Cancer. 2000 Nov;36(17):2191-7. doi: 10.1016/s0959-8049(00)00308-7.
2
Cervical cancer screening in Greece.
Eur J Cancer. 2000 Nov;36(17):2227-32. doi: 10.1016/s0959-8049(00)00314-2.
3
Cytological screening for cervical cancer in the province of Limburg, Belgium.比利时林堡省的宫颈癌细胞学筛查。
Eur J Cancer Prev. 2011 Jan;20(1):18-24. doi: 10.1097/CEJ.0b013e32833ecbc6.
4
Cervical cancer screening in Germany.德国的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2221-6. doi: 10.1016/s0959-8049(00)00313-0.
5
Cervical cancer screening in Italy.意大利的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2235-9. doi: 10.1016/s0959-8049(00)00316-6.
6
Cervical cancer screening in Spain.
Eur J Cancer. 2000 Nov;36(17):2250-4. doi: 10.1016/s0959-8049(00)00319-1.
7
The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.挪威1992 - 2000年宫颈癌筛查项目:巴氏涂片覆盖率及宫颈癌发病率的变化
J Med Screen. 2002;9(2):86-91. doi: 10.1136/jms.9.2.86.
8
[Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].[2007 - 2009年波兰宫颈癌筛查项目的参与率]
Ginekol Pol. 2010 Sep;81(9):655-63.
9
Cervical cancer screening in Austria.奥地利的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2189-90. doi: 10.1016/s0959-8049(00)00322-1.
10
Cervical cancer screening programme in Finland.芬兰的宫颈癌筛查项目。
Eur J Cancer. 2000 Nov;36(17):2209-14. doi: 10.1016/s0959-8049(00)00311-7.

引用本文的文献

1
Never and under cervical cancer screening in Switzerland and Belgium: trends and inequalities.瑞士和比利时的宫颈癌筛查现状:趋势与不平等。
BMC Public Health. 2020 Oct 7;20(1):1517. doi: 10.1186/s12889-020-09619-z.
2
The impact of regional screening policies on the diffusion of cancer screening participation in Belgium: time trends in educational inequalities in Flanders and Wallonia.区域筛查政策对比利时癌症筛查参与率普及的影响:佛兰德斯和瓦隆地区教育不平等的时间趋势。
BMC Health Serv Res. 2018 Dec 4;18(1):943. doi: 10.1186/s12913-018-3746-x.
3
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
根据宫颈癌筛查国际指南验证 Xpert HPV 检测的实验室内和实验室间重现性。
Virol J. 2018 Oct 29;15(1):166. doi: 10.1186/s12985-018-1076-6.
4
A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium.一项关于比利时成年女性浸润性宫颈癌患者人乳头瘤病毒(HPV)类型分布的横断面、多中心流行病学研究。
Facts Views Vis Obgyn. 2015;7(2):101-8.
5
Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).根据个人健康保险数据评估宫颈癌筛查的参与情况以及子宫颈诊断和治疗程序的使用情况(比利时,2002 - 2006年)
PLoS One. 2014 Apr 1;9(4):e92615. doi: 10.1371/journal.pone.0092615. eCollection 2014.
6
Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.多种高病毒载量的人乳头瘤病毒感染与宫颈病变有关,但不能区分宫颈异常的等级。
J Clin Microbiol. 2013 May;51(5):1458-64. doi: 10.1128/JCM.00087-13. Epub 2013 Feb 27.
7
High burden of breast cancer in Belgium: recent trends in incidence (1999-2006) and historical trends in mortality (1954-2006).比利时乳腺癌负担沉重:发病率的近期趋势(1999-2006 年)和死亡率的历史趋势(1954-2006 年)。
Arch Public Health. 2011 Oct 24;69(1):2. doi: 10.1186/0778-7367-69-2.
8
Positive test results motivate GPs to continue screening in a chlamydia prevalence study.在一项衣原体患病率研究中,阳性检测结果促使全科医生继续进行筛查。
Br J Gen Pract. 2003 Aug;53(493):640-1.
9
Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women.用于检测佛兰德女性人乳头瘤病毒DNA并进行分型的薄层液基宫颈细胞学检查和聚合酶链反应
Br J Cancer. 2003 Feb 24;88(4):560-6. doi: 10.1038/sj.bjc.6600756.